Lancovutide (Moli1901) Inhalation Solution Study in Adolescents and Adults With Cystic Fibrosis

Clinical trial NCT00671736 · COMPLETED

Trial details

NCT number: NCT00671736
Sponsor: AOP Orphan Pharmaceuticals AG
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2007-10-01
Primary completion: 2009-07-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.